Test Price
600 AED✅ Home Collection Available
Estrogen Receptor (ER) & Progesterone Receptor (PR) IHC Test in UAE | 600 AED | 2026 DHA Guidelines
تحليل مستقبلات الإستروجين والبروجستيرون (IHC ER-PR) في الإمارات | 600 درهم | معتمد من هيئة الصحة بدبي
Executive Summary | ملخص تنفيذي
- 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited immunohistochemistry processing. حساسية تشخيصية 99.9% عبر معالجة نسيجية مناعية معتمدة من الأيزو.
- Premium Logistics: Hospital‑grade home collection using ISO‑certified cold‑chain transport and VIP mobile phlebotomy (for FFPE pickup).
- Post‑Test Clinical Guidance: Complimentary telephonic interpretation of results with a DHA‑licensed oncologist/pathologist.
- Insurance & Billing: Direct billing verification and pre‑approval via WhatsApp at +971 54 548 8731.
Test Overview
The ER/PR IHC test quantitatively assesses estrogen receptor (ER) and progesterone receptor (PR) protein expression in breast cancer tissue using standardized immunohistochemistry. This test is the cornerstone for determining endocrine responsiveness and guiding adjuvant hormonal therapy in invasive breast carcinoma. In the UAE, our ISO‑certified laboratory delivers definitive results within 3 days from a FFPE tissue block, supporting oncologists, surgical pathologists, and anti‑aging specialists in personalised care.
| Feature | Our ER/PR IHC Test | Closest Alternative (Standard IHC) |
|---|---|---|
| Precision / Accuracy | 99.9% sensitivity, ISO 9001:2015 validated, automated digital scoring (Allred/H‑score) | Variable inter‑laboratory agreement; manual semi‑quantitative scoring |
| Methodology | Full‑automated IHC with FDA‑approved primary antibodies (SP1, PgR 636) on Bond‑III platform | Manual or semi‑automated IHC, non‑standardised antibody clones |
| Turnaround Time | 3 Days | 3–7 days, no home collection/logistics |
Physician Insight & Safety Protocol
“As a Senior Consultant Pathologist, I ensure every ER/PR IHC result is clinically correlated with histology, radiology, and the patient’s menopausal status. A positive result is a powerful guide for tamoxifen or aromatase inhibitor therapy, but a negative result in a young woman demands urgent multi‑disciplinary oncologic evaluation. Never interpret IHC in isolation.”
— Dr. PRABHAKAR REDDY, DHA License 61713011
⚠️ Medication Warning
Do not discontinue prescribed medications, especially tamoxifen, aromatase inhibitors, or hormone replacement therapy, without explicit instruction from your treating physician. IHC receptor status alone does not constitute a treatment change order.
Safety Exclusion Criteria & ER Red Flags
- Insufficient invasive tumor (<100 cells) – test may be indeterminate; repeat biopsy recommended.
- Decalcified bone specimens (acid decalcification) may cause false‑negative ER/PR; avoid if possible.
- ER‑negative/PR‑negative tumor in a premenopausal woman under 35 – immediate oncology referral for genetic counselling and aggressive treatment.
- Prolonged cold‑ischaemic time (>1 hour) or improper formalin fixation may compromise antigenicity.
- Patients with active, severe allergies to mouse/rabbit proteins (rare) – inform laboratory.
If you experience sudden breast mass enlargement, skin ulceration, or severe pain while awaiting results, go to the emergency department immediately.
Patient FAQ & Clinical Guidance
What is the ER/PR IHC test for breast cancer?
The ER/PR IHC test measures estrogen and progesterone receptor expression in breast cancer tissue to guide hormone therapy decisions. It tells your oncologist whether the tumour is likely to respond to tamoxifen or aromatase inhibitors, directly shaping your treatment plan.
How is the performed and what sample is required?
We use immunohistochemistry on FFPE tissue blocks to detect ER and PR proteins in breast cancer cells. This process uses validated antibodies and automated digital scoring; a new biopsy is not needed if an existing block is available—we arrange a free FFPE pickup from your hospital.
متى أحصل على نتائج تحليل مستقبلات الإستروجين والبروجستيرون؟
تصدر نتائجك خلال 3 أيام عمل مع استشارة هاتفية مجانية من طبيب مختص لشرح التقرير بدقة. بعدها يمكن لطبيبك المعالج أن يحدد العلاج الهرموني المناسب بناءً على حالة المستقبلات والدرجة النسيجية.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians